Yurii Husiev
Gast-onderzoeker
- Naam
- Dr. Y. Husiev
- ORCID iD
- 0000-0003-3776-9844
Gast-onderzoeker
- Husiev Y. (20 maart 2025), Towards near-infrared light-activated combination chemotherapy (Dissertatie. Leiden Institute of Chemistry (LIC), Faculty of Science, Leiden University). Promotor(en): Bonnet S. & Bouwman E.
- Hakkennes M.L.A., Regeni I., Husiev Y., Andreeva V.D., Siegler M.A., Buda F. & Bonnet S.A. (2025), Structure over states: planarity, not energy, dictates photoactivation in Ru(II) PACT agents, Journal of the American Chemical Society 147(39): 35767-35787.
- Husiev Y., Götzfried S.K., Hakkennes M.L.A., Kotova D., Tutein Nolthenius I., Griend C.J. van de, Johns A.C., Abyar S., Siegler M.A., Kornienko A. & Bonnet S.A. (2025), A sterically open ruthenium-based photocage activated by red and far-red light for a wide range of drugs, Journal of the American Chemical Society 147(48): 44356-44371.
- Bretin L.R., Husiev Y., Vadde R., Zhang L., Hakkennes M.L.A., Abyar S., Johns A.C., Le Dévédec S.E., Betancourt T., Kornienko A. & Bonnet S.A. (2024), Red‐light activation of a microtubule polymerization inhibitor via amide functionalization of the ruthenium photocage, Angewandte Chemie (International Edition) 63(5): e202316425.
- Verbeet W., Husiev Y. & Bonnet S.A. (2024), Simple and efficient method for mono‐ and di‐amination of polypyridine N‐oxides, European Journal of Organic Chemistry 27(14): e202400054.
- Abyar S., Huang L., Husiev Y., Bretin L.R., Chau B., Vadde R., Wildeman J.H., Belfor K., Wijyay L.S., Noord V.E. van der, Harms A.C., Siegler M.A., Le Dévédec S.E. & Bonnet S.A. (2024), Oxygen-dependent interactions between the ruthenium cage and the photoreleased inhibitor in NAMPT-targeted photoactivated chemotherapy, Journal of Medicinal Chemistry 67(13): 11086–11102.
- Fiala J., Roach T., Holzinger A., Husiev Y., Delueg L., Hammerle F., Sanchez Armengolm E., Schöbel H., Bonnet S.A., Laffleur F., Kranner I., Lackner M. & Siewert B. (2024), The light-activated effect of natural anthraquinone parietin against candida auris and other fungal priority pathogens, Planta Medica 90(07/08): 588-594.
- Zhang L., Zhao G., Dalrymple T., Husiev Y., Bronkhorst H., Fom-Cuni G., Lopes-Bastos B.M., Snaar-Jagalska B.E. & Bonnet S.A: (2024), Cyclic ruthenium-peptide prodrugs penetrate the blood–brain barrier and attack glioblastoma upon light activation in orthotopic zebrafish tumor models, ACS Central Science 10(12): 2294-2311.
- Zhang L., Wang P., Zhou X.Q., Bretin L.R., Zeng X., Husiev Y., Polanco Rivas E.A., Zhao G., Wijaya L.S., Biver T., Le Dévédec S.E., Sun W. & Bonnet S. (2023), Cyclic ruthenium-peptide conjugates as integrin-targeting phototherapeutic prodrugs for the treatment of brain tumors, Journal of the American Chemical Society 145(27): 14963-14980.
- Hammerle F., Fiala J., Höck A., Huymann L., Vrabl P., Husiev Y., Bonnet S., Peintner U. & Siewert B. (2023), Fungal anthraquinone photoantimicrobials challenge the dogma of Cationic photosensitizers, Journal of Natural Products 86(10): 2247-2257.
- Geest E.P. van, Götzfried S. K., Klein D. M., Salitra N., Popal S., Husiev Y., Griend C.J. van der, Zhou X., Siegler M. A., Schneider G.F. & Bonnet S.A. (2023), A Lock-and-Kill anticancer photoactivated chemotherapy agent: this article is part of a Special Issue celebrating the 50thAnniversary of the American Society for Photobiology, Photochemistry and Photobiology 99(2): 777-786.
- Chen Q., Cuello-Garibo J.A., Bretin L.R., Zhang L., Ramu V., Aydar Y., Batsiun Y., Bronkhorst S., Husiev Y., Beztsinna N., Chen L., Zhou X.Q., Schmidt C., Ott I., Jager M.J., Brouwer A.M., Snaar-Jagalska B.E. & Bonnet S.A. (2022), Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model, Chemical Science 13(23): 6899-6919.